期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 64, 期 1, 页码 298-325出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.0c01704
关键词
-
资金
- National Natural Science Foundation of China [81773571, 81973173]
- Jiangsu Province Funds for Excellent Young Scientists [BK20170088]
- Fundamental Research Funds for the Central Universities [2632019ZD14]
The study focuses on the role of reactive oxygen species in various diseases and the development of drugs for the targeted treatment and precise diagnosis of ROS-related diseases, also discussed are the activation mechanisms of ROS-responsive prodrugs.
Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant differences in ROS levels between the nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeted treatment and precise diagnosis of ROS-related diseases. This review will summarize and provide insight into recent advances in ROS-responsive prodrugs, fluorescent probes, and theranostic prodrugs, with applications to different ROS-related diseases and various subcellular organelle-targetable and disease-targetable features. The ROS-responsive moieties, the self-immolative linkers, and the typical activation mechanism for the ROS-responsive release are also summarized and discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据